Logo image of ACX.DE

BET-AT-HOME.COM AG (ACX.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:ACX - DE000A0DNAY5 - Common Stock

2.22 EUR
-0.06 (-2.63%)
Last: 12/15/2025, 5:10:58 PM
Fundamental Rating

3

Overall ACX gets a fundamental rating of 3 out of 10. We evaluated ACX against 57 industry peers in the Hotels, Restaurants & Leisure industry. While ACX has a great health rating, there are worries on its profitability. ACX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACX has reported negative net income.
ACX had a positive operating cash flow in the past year.
In multiple years ACX reported negative net income over the last 5 years.
Of the past 5 years ACX 4 years had a positive operating cash flow.
ACX.DE Yearly Net Income VS EBIT VS OCF VS FCFACX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

ACX has a worse Return On Assets (-12.04%) than 80.70% of its industry peers.
ACX's Return On Equity of -25.45% is in line compared to the rest of the industry. ACX outperforms 43.86% of its industry peers.
Industry RankSector Rank
ROA -12.04%
ROE -25.45%
ROIC N/A
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ACX.DE Yearly ROA, ROE, ROICACX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

In the last couple of years the Operating Margin of ACX has declined.
With an excellent Gross Margin value of 78.75%, ACX belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
ACX's Gross Margin has been stable in the last couple of years.
ACX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.75%
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
ACX.DE Yearly Profit, Operating, Gross MarginsACX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

ACX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACX has about the same amount of shares outstanding.
The number of shares outstanding for ACX remains at a similar level compared to 5 years ago.
The debt/assets ratio for ACX has been reduced compared to a year ago.
ACX.DE Yearly Shares OutstandingACX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ACX.DE Yearly Total Debt VS Total AssetsACX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

ACX has an Altman-Z score of 2.38. This is not the best score and indicates that ACX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.38, ACX perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
The Debt to FCF ratio of ACX is 1.78, which is an excellent value as it means it would take ACX, only 1.78 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.78, ACX belongs to the best of the industry, outperforming 87.72% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that ACX is not too dependend on debt financing.
The Debt to Equity ratio of ACX (0.04) is better than 91.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.78
Altman-Z 2.38
ROIC/WACCN/A
WACC6.92%
ACX.DE Yearly LT Debt VS Equity VS FCFACX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.61 indicates that ACX should not have too much problems paying its short term obligations.
ACX has a better Current ratio (1.61) than 91.23% of its industry peers.
ACX has a Quick Ratio of 1.61. This is a normal value and indicates that ACX is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.61, ACX belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61
ACX.DE Yearly Current Assets VS Current LiabilitesACX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.34% over the past year.
The Revenue has been growing slightly by 6.56% in the past year.
ACX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.26% yearly.
EPS 1Y (TTM)29.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.98%
Revenue 1Y (TTM)6.56%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%-16.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACX.DE Yearly Revenue VS EstimatesACX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
ACX.DE Yearly EPS VS EstimatesACX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

4

4. Valuation

4.1 Price/Earnings Ratio

ACX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 3.55 indicates a rather cheap valuation of ACX.
ACX's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACX is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.79, ACX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.55
ACX.DE Price Earnings VS Forward Price EarningsACX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 22.11
EV/EBITDA N/A
ACX.DE Per share dataACX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ACX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BET-AT-HOME.COM AG

FRA:ACX (12/15/2025, 5:10:58 PM)

2.22

-0.06 (-2.63%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-05 2025-11-05
Earnings (Next)03-26 2026-03-26
Inst Owners0.21%
Inst Owner ChangeN/A
Ins Owners58.83%
Ins Owner ChangeN/A
Market Cap15.58M
Revenue(TTM)76.00M
Net Income(TTM)-6.31M
Analysts80
Price Target5.61 (152.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.55
P/S 0.2
P/FCF 22.11
P/OCF 21.83
P/B 0.63
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.63
Fwd EY28.21%
FCF(TTM)0.1
FCFY4.52%
OCF(TTM)0.1
OCFY4.58%
SpS11.11
BVpS3.53
TBVpS3.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.04%
ROE -25.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.75%
FCFM 0.9%
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
F-Score4
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.78
Debt/EBITDA N/A
Cap/Depr 0.94%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z 2.38
F-Score4
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)22.88%
Cap/Depr(5y)42.26%
Cap/Sales(3y)0.89%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.98%
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.56%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%-16.14%
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.02%
EBIT growth 3Y-59.94%
EBIT growth 5Y-53.14%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.26%
FCF growth 3Y-55.42%
FCF growth 5Y-51.16%
OCF growth 1Y-88.03%
OCF growth 3Y-57.74%
OCF growth 5Y-51.62%

BET-AT-HOME.COM AG / ACX.DE FAQ

Can you provide the ChartMill fundamental rating for BET-AT-HOME.COM AG?

ChartMill assigns a fundamental rating of 3 / 10 to ACX.DE.


What is the valuation status of BET-AT-HOME.COM AG (ACX.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to BET-AT-HOME.COM AG (ACX.DE). This can be considered as Fairly Valued.


How profitable is BET-AT-HOME.COM AG (ACX.DE) stock?

BET-AT-HOME.COM AG (ACX.DE) has a profitability rating of 2 / 10.


What is the financial health of BET-AT-HOME.COM AG (ACX.DE) stock?

The financial health rating of BET-AT-HOME.COM AG (ACX.DE) is 7 / 10.